91 related articles for article (PubMed ID: 8244779)
1. Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancer.
Glew SS; Duggan-Keen M; Ghosh AK; Ivinson A; Sinnott P; Davidson J; Dyer PA; Stern PL
Hum Immunol; 1993 Jul; 37(3):157-64. PubMed ID: 8244779
[TBL] [Abstract][Full Text] [Related]
2. Cervical carcinoma: human papillomavirus infection and HLA-associated risk factors in the Spanish population.
Montoya L; Saiz I; Rey G; Vela F; Clerici-Larradet N
Eur J Immunogenet; 1998 Oct; 25(5):329-37. PubMed ID: 9805655
[TBL] [Abstract][Full Text] [Related]
3. HLA class I expression and HPV-16 sequences in premalignant and malignant lesions of the cervix.
Torres LM; Cabrera T; Concha A; Oliva MR; Ruiz-Cabello F; Garrido F
Tissue Antigens; 1993 Feb; 41(2):65-71. PubMed ID: 8386400
[TBL] [Abstract][Full Text] [Related]
4. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.
Apple RJ; Erlich HA; Klitz W; Manos MM; Becker TM; Wheeler CM
Nat Genet; 1994 Feb; 6(2):157-62. PubMed ID: 8162070
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer.
Ghaderi M; Nikitina Zake L; Wallin K; Wiklund F; Hallmans G; Lenner P; Dillner J; Sanjeevi CB
Hum Immunol; 2001 Oct; 62(10):1153-8. PubMed ID: 11600224
[TBL] [Abstract][Full Text] [Related]
7. DQA1 and DQB1 genes in patients with squamous cell carcinoma of the cervix: relationship to human papillomavirus infection and prognosis.
Helland A; Børresen AL; Kristensen G; Rønningen KS
Cancer Epidemiol Biomarkers Prev; 1994 Sep; 3(6):479-86. PubMed ID: 8000298
[TBL] [Abstract][Full Text] [Related]
8. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
Glew SS; Duggan-Keen M; Cabrera T; Stern PL
Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
[TBL] [Abstract][Full Text] [Related]
9. Association of human leukocyte antigen-B1*03 with cervical cancer in Japanese women aged 35 years and younger.
Nawa A; Nishiyama Y; Kobayashi T; Wakahara Y; Okamoto T; Kikkawa F; Suganuma N; Goto S; Kuzuya K; Tomoda Y
Cancer; 1995 Jan; 75(2):518-21. PubMed ID: 7812922
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigen class II alleles and risk of cervical cancer in China.
Wu Y; Liu B; Lin W; Xu Y; Li L; Zhang Y; Chen S; Lin Z; Xu A
Hum Immunol; 2007 Mar; 68(3):192-200. PubMed ID: 17349874
[TBL] [Abstract][Full Text] [Related]
11. HLA DQ-DR haplotype and susceptibility to cervical carcinoma: indications of increased risk for development of cervical carcinoma in individuals infected with HPV 18.
Allen M; Kalantari M; Ylitalo N; Pettersson B; Hagmar B; Scheibenpflug L; Johansson B; Petterson U; Gyllensten U
Tissue Antigens; 1996 Jul; 48(1):32-7. PubMed ID: 8864172
[TBL] [Abstract][Full Text] [Related]
12. Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women.
Gregoire L; Lawrence WD; Kukuruga D; Eisenbrey AB; Lancaster WD
Int J Cancer; 1994 May; 57(4):504-7. PubMed ID: 8181853
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies.
Wang SS; Hildesheim A; Gao X; Schiffman M; Herrero R; Bratti MC; Sherman ME; Barnes WA; Greenberg MD; McGowan L; Mortel R; Schwartz PE; Zaino RJ; Glass AG; Burk RD; Karacki P; Carrington M
J Infect Dis; 2002 Sep; 186(5):598-605. PubMed ID: 12195346
[TBL] [Abstract][Full Text] [Related]
14. HLA expression in pre-invasive cervical neoplasia in relation to human papilloma virus infection.
Glew SS; Connor ME; Snijders PJ; Stanbridge CM; Buckley CH; Walboomers JM; Meijer CJ; Stern PL
Eur J Cancer; 1993; 29A(14):1963-70. PubMed ID: 8280490
[TBL] [Abstract][Full Text] [Related]
15. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ
Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722
[TBL] [Abstract][Full Text] [Related]
16. Human leukocyte antigen class II and cervical cancer risk: a population-based study.
Madeleine MM; Brumback B; Cushing-Haugen KL; Schwartz SM; Daling JR; Smith AG; Nelson JL; Porter P; Shera KA; McDougall JK; Galloway DA
J Infect Dis; 2002 Dec; 186(11):1565-74. PubMed ID: 12447731
[TBL] [Abstract][Full Text] [Related]
17. Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer.
Combita AL; Bravo MM; Touzé A; Orozco O; Coursaget P
Int J Cancer; 2002 Feb; 97(6):796-803. PubMed ID: 11857357
[TBL] [Abstract][Full Text] [Related]
18. Role of human papillomavirus in determining the HLA associated risk of cervical carcinogenesis.
Mehal WZ; Lo YM; Herrington CS; Evans MF; Papadopoulos MC; Odunis K; Ganesan TS; McGee JO; Bell JI; Fleming KA
J Clin Pathol; 1994 Dec; 47(12):1077-81. PubMed ID: 7876378
[TBL] [Abstract][Full Text] [Related]
19. Expression of major histocompatibility class II antigens by Langerhans' cells in cervical intraepithelial neoplasia.
Hughes RG; Norval M; Howie SE
J Clin Pathol; 1988 Mar; 41(3):253-9. PubMed ID: 2834416
[TBL] [Abstract][Full Text] [Related]
20. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
